Regulatory News
Thursday, May 5, 2016
BRIEF-Valeant Pharmaceuticals International says forms new patient access and pricing committee
* Board of directors will oversee patient access and pricing
committee
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment